Our mass tort restructuring team has been at the forefront of the largest and most complex mass tort-driven bankruptcies of the past two decades.
We’ve played pivotal roles in headline-making bankruptcies, including Purdue Pharma, Mallinckrodt, Endo, Red River Talc, Boy Scouts, other cases involving asbestos and environmental mass torts, and substantially all bankruptcies of major opioid manufacturers and defendants over the past five years.
We represent key tort and non-tort constituencies of companies facing mass tort and other substantial liabilities including ad hoc creditor groups and official committees, secured creditors, tort claimants (including governmental entities and state attorneys general), and the companies and sponsors facing these liabilities. Our clients benefit from our understanding of the diverse perspectives of all the major stakeholders in negotiations.
We drive favorable outcomes for clients, creatively structuring resolutions of mass tort claims and implementing resolutions both out of court and through Chapter 11 plans of reorganization, and strategically dual-tracking litigation and negotiation efforts to maximize recoveries for our clients. We are renowned for pioneering development of bespoke trust structures tailored to meet specific client needs, including to address issues of abatement, transferability of trust units and equity distribution, and the pooling of insurance proceeds among different varieties of claimants to drive increased recoveries. On the company side, we work to maximize value by facilitating the sale of business lines free of mass tort and other successor liabilities, as well as to facilitate creative solutions for resolving potential liabilities out of court.
